Pixium Vision announces reaching its enrollment target in the European pivotal trial PRIMAvera and implantations planned to be completed by end 2022 The target number of 38 patients have
Pixium Vision announces participation in upcoming scientific conferences in September 2022 Paris, France, August 29, 2022 - 07:00 CET - Pixium Vision SA (Euronext Growth Paris - FR0011950641;
Pixium Vision to attend H.C. Wainwright 2nd Annual Ophthalmology Virtual Conference on August 17, 2022 Paris, France, August 11, 2022 - 19:00 CET - Pixium Vision SA (Euronext Growth Paris - FR0011950641
Pixium Vision announces successful implantation of first patient in the Netherlands in Prima System European pivotal trial PRIMAvera PRIMAvera clinical site opens at the Rotterdam Eye Hospital in the. | July 26, 2022
Pixium Vision announces its financial results for H1 2022 and provides a business update Cash position at 30 June 2022: €7,2 millionPRIMAvera European pivotal study ongoing and on track to report